Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin ER for postherpetic neuralgia
CTR20150477Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pregabalin in postherpetic neuralgia (PHN), sponsored by Hengrui Therapeutics. Started Jul 2015; status: completed.
02
Drugs
pregabalin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on CTR20150477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150477.